The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. The Company has operations in 11 countries across five continents. Canopy Growth operates ten licensed cannabis production sites with over 2.4 million square feet of production capacity, including over 500,000 square feet of GMP-certified production space. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.Ĭanopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Simplified.Ĭanopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. The Catalyst Peer Mentorship Program is committed to equipping healthcare professionals with the support they need to optimize patient outcomes and prioritize patient safety, in this case, through peer to peer education and training The need for increased healthcare education and support to develop competencies in cannabinoid medicine is imperative and our goal is to educate physicians and other healthcare professionals, while simplifying the dialogue around medical cannabis Schecter has trained thousands of physicians and other healthcare professionals on determining where and how medical cannabis may be implemented as a treatment option for their patients. As a recognized expert in cannabinoid medicine, Dr.
Schecter along with Canopy Growth’s medical outreach team. Specialized mentors have been identified and recruited to participate in the program by Dr.
There will also be opportunities for physicians to participate in Continuing Professional Development (CPD) programs regarding cannabinoid medicine. The Catalyst Program will connect Canadian physicians with specialist mentors through telephone, email, fax and videoconferencing to provide case-by-case support and guidance on issues pertaining to the clinical aspects of prescribing medical cannabis. Said Mark Zekulin, President & Co-CEO, Canopy Growth. Adding a peer education element will increase the number of credible educational resources available to Canadian healthcare professionals seeking more cannabis-specific information We have spent the last four years engaging physicians through a number of educational initiatives including accredited education.
The Catalyst Program aims to do just that.
To address this education gap, the Company believes it is important that educational resources and support networks are provided to healthcare professionals in the form of qualified peer mentors who possess advanced knowledge of medical cannabis. Though there are nearly 300,000 registered medical cannabis patients in Canada, still less than one in five physicians feel comfortable prescribing cannabis as a treatment option. Danial Schecter, Co-founder of the Cannabinoid Medical Clinic, today announced a new Catalyst Peer Mentorship Program (“Catalyst Program”) which will link physicians from across the country with colleagues who possess advanced knowledge of the cannabis field in order to provide case-by-case support.Ĭanada’s regulatory framework for cannabis in Canada is evolving quickly, creating more and more interest from patients and healthcare practitioners in Canada. Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) and its wholly owned subsidiary Spectrum Cannabis, together with Dr.